Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Endocrinology - 1 Feb 2005

Warden Stuart J, Robling Alexander G, Sanders Megan S, Bliziotes Michael M, Turner Charles H

Abstract excerpt

Selective serotonin-reuptake inhibitors (SSRIs) antagonize the serotonin (5-hydroxytryptamine) transporter (5-HTT), and are frequently prescribed to children and adolescents to treat depression. However, recent findings of functional serotonergic pathways in bone cells and preliminary clinical ev...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Density
Share to Bone Development
Share to Fluoxetine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mechanoreceptors

Share to Mice, Inbred Strains

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin Plasma Membrane Transport Proteins

Share to Testosterone

Source

Identifiers

PMID: 15539550
DOI: 10.1210/en.2004-1259

Genes

HTT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15539550-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.PMID 15539550Read ↗

Selective serotonin reuptake inhibitor exposure alters osteoblast gene expression and craniofacial development in miceSemantic proximity Read ↗

Peripheral serotonin-mediated system suppresses bone development and regeneration via serotonin 6 G-protein-coupled receptorSemantic proximity Read ↗

Efficacy of serotonin inhibition in mouse models of bone loss.Semantic proximity Read ↗

Effect of bisphosphonates on the rapidly growing male murine skeleton.Semantic proximity Read ↗

Constitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats.Semantic proximity Read ↗

Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.Semantic proximity Read ↗

Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral density.Semantic proximity Read ↗

Bone growth in juvenile rhesus monkeys is influenced by 5HTTLPR polymorphisms and interactions between 5HTTLPR polymorphisms and fluoxetine.Semantic proximity Read ↗

The Role of Serotonin and Neurotransmitters During Craniofacial DevelopmentSemantic proximity Read ↗

Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.Semantic proximity Read ↗

Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.Semantic proximity Read ↗

Sex steroids during bone growth: a comparative study between mouse models for hypogonadal and senile osteoporosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.